Tyra Biosciences TYRA
NASDAQ TYRA
$21.01 -0.86 (-3.93%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tyra Biosciences (TYRA) Cash from Financing Activities (2020 - 2026)

Updated

Tyra Biosciences (TYRA) recorded Cash from Financing Activities of $2.1 million in Q2 2026, up 260.5% from $583,000 a year earlier but down 98.7% from the prior quarter.

Analysis

Tyra Biosciences (TYRA) Cash from Financing Activities (2020 - 2026) Analysis & Trends

On a TTM basis, Tyra Biosciences' Cash from Financing Activities came in at $167.82 million as of Jun 30, 2026; for FY2025, it came in at $8.1 million, down 96.0% from FY2024.

  • Annual Cash from Financing Activities has a five-year compound annual growth rate of -19.1% (FY2020 to FY2025).
  • Across earlier years, Cash from Financing Activities came in at $202.14 million in FY2024, $1.54 million in FY2023 (+143.2%), $632,000 in FY2022 (-99.8%) and $311.35 million in FY2021.
  • Quarterly Cash from Financing Activities has ranged from -$1.51 million in Q4 2021 to $200.32 million in Q1 2024 over the past five years.
  • On a year-over-year basis, Cash from Financing Activities rose in five of the last seven quarters, with growth averaging 135.0%.
  • Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 563.3% in Q4 2025, against a decline of 99.8% in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $160.38 million (Q1 2026), $4.68 million (Q4 2025) and $647,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Tyra Biosciences 1.30 Bn 1.30 Bn - 2.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.10 Mn
Mar 31, 2026 160.38 Mn
Dec 31, 2025 4.68 Mn
Sep 30, 2025 647,000.00
Jun 30, 2025 583,000.00
Mar 31, 2025 2.19 Mn
Dec 31, 2024 706,000.00
Sep 30, 2024 743,000.00
Jun 30, 2024 373,000.00
Mar 31, 2024 200.32 Mn
Dec 31, 2023 324,000.00
Sep 30, 2023 467,000.00
Jun 30, 2023 370,000.00
Mar 31, 2023 376,000.00
Dec 31, 2022 3,000.00
Sep 30, 2022 364,000.00
Jun 30, 2022 27,000.00
Mar 31, 2022 238,000.00
Dec 31, 2021 -1.51 Mn
Sep 30, 2021 183.44 Mn
API Access

Tyra Biosciences Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=TYRA&period=max&api_key=YOUR_API_KEY